secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001140361-23-000924
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis reports preliminary Q4 revenue of $2.3M, up 42% YoY; FY22 revenue $8.5M, up 8%
--------------------------------------------------------------------------------

- Preliminary Q4 2022 revenue $2.3M, up 42% YoY; full-year 2022 revenue $8.5M, up 8% YoY.
- Pediatrics segment grew 92% YoY; Heart Failure +47%; Critical Care +24%.
- Growth driven by commercial team expansion and market penetration beyond heart failure.
- CEO cites strong sales momentum and commitment to making Aquadex SmartFlow standard of care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123000924/0001140361-23-000924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123000924/brhc10046422_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-000924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer